CIK 0001396814 · Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510619477
- Phone
- 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- 4 Planned sale Senior Vice President, Finance sold 6,366 shares at an average $38.42 ($244,606)
- 4 Grant or award Chief Financial Officer acquired 9,000 shares (grant or award)
- 4 Grant or award Director acquired 1,775 shares (grant or award)
- 4 Grant or award Director acquired 1,775 shares (grant or award)
- 4 Grant or award Director acquired 1,775 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 1,775 shares (grant or award)
- 4 Grant or award Director acquired 1,775 shares (grant or award)
- 4 Grant or award Director acquired 1,775 shares (grant or award)
- 4 Planned sale Director sold 15,000 shares at $37.04 ($555,600)
- 4 Open-market sale Chief Medical Officer sold 3,636 shares at an average $38.42 ($139,680)
- 4 Open-market sale Chief Administrative Officer sold 2,658 shares at an average $38.42 ($102,110)
- 4 Open-market sale CEO and Chairman sold 10,384 shares at an average $38.41 ($398,885)
- 4 Open-market sale Chief Clinical Officer sold 961 shares at an average $38.42 ($36,919)
- 4 Open-market sale Senior Vice President, Finance sold 1,207 shares at an average $38.42 ($46,369)
- 4 Open-market sale Chief Financial Officer sold 2,607 shares at an average $38.40 ($100,106)
- 4 Open-market sale President, Rest of World sold 2,153 shares at an average $38.42 ($82,710)
- 4 Planned sale Chief Lgl & Compliance Officer sold 6,788 shares at an average $38.46 ($261,059)
- 4 Open-market sale Chief Customer Officer sold 2,071 shares at an average $38.42 ($79,560)
- 4 Open-market sale Director sold 580 shares at $38.34 ($22,237)
Page 7 of 35 · 695 filings